By Fran Kritz
A panel of University of Maryland (UMD) medicine and pharmacy experts told reporters late last week that research funding cuts to the National Institutes of Health (NIH) and other government agencies, announced by the Trump administration since February, will result in fewer new drugs and vaccines developed and fewer pharmacy students prepared for future roles in research and industry.
During the briefing, Mark T. Gladwin, MD, the dean of the UMD School of Medicine, addressed the